CCG
ELV icon

Catalina Capital Group’s Elevance Health ELV Stock Holding History

Catalina Capital Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,001
Closed -$369K – 248
2024
Q4 		$369K Sell
1,001
-655
-40% -$274K 0.12% 170
2024
Q3 		$861K Buy
1,656
+27
+2% +$14.4K 0.29% 69
2024
Q2 		$883K Buy
1,629
+780
+92% +$412K 0.33% 60
2024
Q1 		$440K Buy
849
+392
+86% +$195K 0.18% 123
2023
Q4 		$216K Buy
+457
New +$211K 0.14% 131

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Catalina Capital Group's ELV Position: Q1 2025 in Review

Catalina Capital Group sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 1,001 shares — an estimated $369K sold.

Catalina Capital Group first reported a position in ELV in Q4 2023 and held it in 5 quarters. The position peaked at $883K in Q2 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Catalina Capital Group reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Catalina Capital Group sold 1,001 Elevance Health shares in Q1 2025, an estimated $369K.
  • Catalina Capital Group first reported a position in Elevance Health in Q4 2023 and held it in 5 quarters.
  • Catalina Capital Group's Elevance Health position peaked at $883K in Q2 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Catalina Capital Group's 13F filing for Q1 2025, filed 21 Apr 2025.